Bosera Szse Chinext Daily (2x) Leveraged Product(07234.HK) rose 4.66% to HKD 10.780
Newtimespace News, as of 11:11 on April 29, Bosera Szse Chinext Daily (2x) Leveraged Product(07234.HK) was quoted at HKD 10.780, up 4.66%. The ETF opened at HKD 10.240, with a high of HKD 10.780 and a low of HKD 10.240. The latest turnover was HKD 4.5852 million, and the turnover rate was 2.68%. The latest NAV per unit is HKD 10.362, with a premium rate of -0.60%. The asset size is approximately HKD 169 million, and the total issuance is 16.30 million units.
Bosera Szse Chinext Daily (2x) Leveraged Product(07234.HK) tracks the ChiNext Index, which is officially compiled and published by the Shenzhen Stock Exchange. The index aims to comprehensively reflect the ChiNext market and provides investors with tradable index products and financial derivatives benchmarks. The index uses the free-float market capitalization weighted average method and selects 100 stocks with large market capitalization and good liquidity from the ChiNext market as sample components, focusing on strategic emerging industries and high-tech sectors.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million